|
|
Volumn 27, Issue 3, 2016, Pages 544-545
|
|
Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATEZOLIZUMAB;
AXITINIB;
BEVACIZUMAB;
DEXAMETHASONE;
EVEROLIMUS;
NIVOLUMAB;
PAZOPANIB;
PEMBROLIZUMAB;
STEROID;
SUNITINIB;
VASCULOTROPIN;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
IMIDAZOLE DERIVATIVE;
INDAZOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
PDCD1 PROTEIN, HUMAN;
PROGRAMMED DEATH 1 RECEPTOR;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
ADULT;
BRAIN EDEMA;
BRAIN METASTASIS;
BRAIN NECROSIS;
CANCER INFILTRATION;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CASE REPORT;
CINGULATE GYRUS;
DISEASE COURSE;
DISEASE DURATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TARGETING;
FEMALE;
HUMAN;
KIDNEY CARCINOMA;
LETTER;
MEDICAL HISTORY;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OFF LABEL DRUG USE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION INJURY;
TREATMENT DURATION;
TREATMENT RESPONSE;
VASOGENIC EDEMA;
ANTAGONISTS AND INHIBITORS;
BRAIN NEOPLASMS;
CARCINOMA, RENAL CELL;
LUNG NEOPLASMS;
RADIATION INJURIES;
SECONDARY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
BEVACIZUMAB;
BRAIN EDEMA;
BRAIN NEOPLASMS;
CARCINOMA, RENAL CELL;
FEMALE;
HUMANS;
IMIDAZOLES;
INDAZOLES;
LUNG NEOPLASMS;
MIDDLE AGED;
PROGRAMMED CELL DEATH 1 RECEPTOR;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
RADIATION INJURIES;
SULFONAMIDES;
|
|
EID: 84959928939
PISSN: 09237534
EISSN: 15698041
Source Type: Journal
DOI: 10.1093/annonc/mdv581 Document Type: Letter |
|
Times cited : (12)
|
|
References (6)
|
